{
    "clinical_study": {
        "@rank": "36897", 
        "arm_group": {
            "arm_group_label": "Intervension", 
            "description": "Lung Flute"
        }, 
        "biospec_descr": {
            "textblock": "Sputum"
        }, 
        "biospec_retention": "Samples With DNA", 
        "brief_summary": {
            "textblock": "We hypothesized that the ability of the Lung Flute to enhance mucus clearance from the lower\n      airways could be used to improve asthma control, if the device is used on a chronic basis.\n      The primary end point of the study is the comparison of Asthma Control Test (ACT) - a\n      validated questionnaire for asthma control and exhaled NO before, during and after using the\n      lung flute.  Several secondary end points were assessed for efficacy and safety, including\n      health status, spirometric lung function, \"stepping down\" controller therapy and daily\n      albuterol use."
        }, 
        "brief_title": "Impact of Lung Flute Therapy on Asthma", 
        "completion_date": {
            "#text": "June 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Persistent Asthma", 
        "condition_browse": {
            "mesh_term": "Asthma"
        }, 
        "detailed_description": {
            "textblock": "This is a 3 month open label study.  We plan to enroll 48 subjects with asthma at the\n      Buffalo General Medical Center Allergy Clinic or the office of Dr. James Cumella.  Inclusion\n      criteria includes:  at least 12 years of age, diagnosis of asthma and no current or previous\n      history of smoking. Exclusion criteria includes:  exacerbation of asthma or hospitalization\n      for asthma within 8 weeks prior to enrollment, predominant chronic obstructive pulmonary\n      disease (COPD) and bronchiectasis by clinical and/or radiological assessment, history of\n      cough syncope, pregnant or nursing women, and inability to comply with study procedures."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  at least 12 years of age\n\n          -  diagnosis of asthma and no current or previous history of smoking.\n\n        Exclusion Criteria:\n\n          -  exacerbation of asthma or hospitalization for asthma within 8 weeks prior to\n             enrollment\n\n          -  predominant COPD and bronchiectasis by clinical and/or radiological assessment\n\n          -  history of cough syncope\n\n          -  pregnant or nursing women\n\n          -  not fluent in English\n\n          -  inability to comply with study procedures."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "12 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "We are seeking patients diagnosed with asthma. All subjects will have already been\n        screened as a consequence of their being established asthma patients at the clinical\n        sites. Patients will be identified and screened by their attending physician who will\n        notify the investigators. The investigators are responsible for recruiting identified\n        subjects."
            }
        }, 
        "enrollment": {
            "#text": "48", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "November 24, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02003521", 
            "org_study_id": "426195-4"
        }, 
        "intervention": {
            "arm_group_label": "Intervension", 
            "description": "A low frequency wave is generated at the mouth by exhaling through a mouthpiece over a laminar surface (Reed) inside the Lung Flute\u00ae. The resulting low frequency acoustic wave that is produced travels retrograde into the lower airways and lung parenchyma and increases mucociliary clearance. Patients expel air with the force required to blow out a single candle. Patients concentrate on producing a low tone through the device while breathing in a proscribed pattern. Twenty repetitions of a single two-breath pattern are performed with the device to complete a diagnostic session.", 
            "intervention_name": "Lung Flute", 
            "intervention_type": "Device"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": "Lung Flute", 
        "lastchanged_date": "December 2, 2013", 
        "location": {
            "contact": {
                "email": "mailto:sasimmun@buffalo.edu", 
                "last_name": "Stanley M Schwartz, MD PhD", 
                "phone": "716-859-2260"
            }, 
            "contact_backup": {
                "last_name": "James Cumella, MD"
            }, 
            "facility": {
                "address": {
                    "city": "Buffalo", 
                    "country": "United States", 
                    "state": "New York", 
                    "zip": "14203"
                }, 
                "name": "Buffalo General Medical Center Allergy Clinic"
            }, 
            "investigator": {
                "last_name": "Stanley A Schwartz, MD PhD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_groups": "1", 
        "official_title": "Impact of Lung Flute Therapy on Asthma", 
        "other_outcome": {
            "description": "reduction in levels of exhaled nitric oxide (NO) a surrogate marker of pulmonary inflammation\nreduction in sputum eosinophils, another surrogate marker of pulmonary", 
            "measure": "Impact of Lung Flute Therapy on Asthma", 
            "safety_issue": "No", 
            "time_frame": "three months"
        }, 
        "overall_contact": {
            "email": "sasimmun@buffalo.edu", 
            "last_name": "Stanley A Schwartz, M.D. PhD", 
            "phone": "716-859-2260"
        }, 
        "overall_contact_backup": {
            "email": "pka@buffalo.edu", 
            "last_name": "Pam Anderson, BS", 
            "phone": "716-888-4841"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "May 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "improvement in quality of life as measured by the validated Asthma Control Test (ACT);", 
            "measure": "Impact of Lung Flute Therapy on Asthma", 
            "safety_issue": "No", 
            "time_frame": "three months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02003521"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "improvement in pulmonary functions", 
            "measure": "Impact of Lung Flute on Asthma", 
            "safety_issue": "No", 
            "time_frame": "three months"
        }, 
        "source": "Medical Acoustics LLC", 
        "sponsors": {
            "collaborator": {
                "agency": "NYSTAR", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "Medical Acoustics LLC", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "November 2013", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "December 2013"
    }
}